CIK 0000875045
- Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330112644
- Phone
- +1 617-679-2000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-12 | Vounatsos Michel Chief Executive Officer | Grant or award · Restricted Stock Unit | +36,320 | 36,320 | ||
| 2018-02-12 | Sandrock Alfred EVP, Chief Medical Officer | Shares withheld for taxes | −598 | $316.63 | $189K | 6,553.38 |
| 2018-02-12 | Sandrock Alfred EVP, Chief Medical Officer | Option exercise | +2,012 | 8,565.38 | ||
| 2018-02-12 | Sandrock Alfred EVP, Chief Medical Officer | Shares withheld for taxes | −718 | $316.63 | $227K | 7,847.38 |
| 2018-02-12 | Sandrock Alfred EVP, Chief Medical Officer | Grant or award · Restricted Stock Unit | +3,315 | 3,315 | ||
| 2018-02-12 | Sandrock Alfred EVP, Chief Medical Officer | Grant or award · Restricted Stock Unit | +8,290 | 8,290 | ||
| 2018-02-12 | Sandrock Alfred EVP, Chief Medical Officer | Option exercise · Restricted Stock Unit | −2,012 | 4,816 | ||
| 2018-02-12 | Sandrock Alfred EVP, Chief Medical Officer | Other disposition · Restricted Stock Unit | −1,398 | 3,418 | ||
| 2018-01-09 | PANGIA ROBERT W Director | Option exercise | +5,832 | $57.83 | $337K | 23,539 |
| 2018-01-09 | PANGIA ROBERT W Director | Sale | −5,832 | $329.65 | $1.9M | 17,707 |
| 2018-01-09 | PANGIA ROBERT W Director | Option exercise · Stock Option (Right to Buy) | −5,832 | 0 | ||
| 2018-01-02 | CAPELLO JEFFREY D EVP & Chief Financial Officer | Grant or award · Restricted Stock Unit | +8,980 | 8,980 | ||
| 2018-01-02 | CAPELLO JEFFREY D EVP & Chief Financial Officer | Grant or award · Performance Stock Unit | +5,390 | 5,390 | ||
| 2017-12-29 | Vounatsos Michel Chief Executive Officer | Purchase | +780 | $320.55 | $250K | 4,879.46 |
| 2017-12-01 | Guindo Chirfi EVP Glob. Mkt Acc & Cust Innov | Grant or award · Restricted Stock Unit | +3,510 | 3,510 | ||
| 2017-12-01 | Guindo Chirfi EVP Glob. Mkt Acc & Cust Innov | Grant or award | +2,350 | 2,350 | ||
| 2017-12-01 | Guindo Chirfi EVP Glob. Mkt Acc & Cust Innov | Grant or award · Restricted Stock Unit | +1,755 | 1,755 | ||
| 2017-12-01 | COVINO GREGORY F VP, Chief Accounting Officer | Shares withheld for taxes | −54 | $319.35 | $17K | 4,542.36 |
| 2017-12-01 | COVINO GREGORY F VP, Chief Accounting Officer | Shares withheld for taxes | −103 | $319.35 | $33K | 4,439.36 |
| 2017-11-29 | SHERWIN STEPHEN A Director | Gift | −250 | 5,734 |
Page 60 of 61 · 1,204 trades